FNAM Evolutionary Genomics Inc.

Evolutionary Genomics, Inc. engages in developing and marketing an interactive information and advertising service. Its gene portfolio includes soybean pest and disease resistance, tomato sweetness and salt tolerance, cotton project, rice yield, wheat stern rust resistance, and cassava disease resistance. The company was founded by Walter Messier and Virginia Orndorff in November 1990 and is headquartered in Castle Rock, CO.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.75    OTCQB
As of 01/14/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  04/08/2011
Outstanding shares:  5,803,396
Average volume:  188
Market cap:   $4,352,547
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -5.77
PS ratio:   0.00
Return on equity:   1,763.39%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy